Impact and Implementation: Alere's VP for Regulatory Affairs on the US FDA Unique Device Identification System

Add bookmark
Ahead of the UDIs and Traceability for Medical Devices Forum 2014, Simon Richards, VP for Regulatory Affairs, EME at Alere, joins Andrea Charles from Pharma IQ to discuss the benefits of a well-built unique device identification (UDI) system, developing a strategy for implementation and future perspectives for medical device manufacturers. Pharma IQ: What impact is the US FDA Unique Device Identification System Final Rule having on your company? S Richards: It is having a very great effec...
To continue reading this story get free access

Upcoming Events

Pharmaceutical Launch Excellence Summit

1 - 3 December, 2026

Novotel Amsterdam City, Netherlands

Pharmaceutical Launch Excellence Summit

SmartLab Exchange Europe

22 - 23 February 2027

Leonardo Royal Hotel Amsterdam, Netherlands

SmartLab Exchange Europe

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended